Millennium Pharmaceuticals, Inc.

Author:  

Publisher: Future Medicine

ISSN: 1741-0541

Source: Personalized Medicine, Vol.1, Iss.1, 2004-12, pp. : 131-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Millennium Pharmaceuticals, Inc. is committed to making a difference in people’’s lives by developing breakthrough therapies for important diseases based on pre-eminent science and drug development. The company’’s discovery process is built upon its deep understanding of genomics and biology by a research and development approach centered on a fundamental understanding of the basic cellular and genetic mechanisms of diseases, and by focusing on the development of personalized medicine. Over the past decade, Millennium has evolved into a fully integrated biotechnology company, with state-of-the-art discovery, development and commercial capabilities. But the company remains very much rooted in its gene-based, biology heritage as the practice of medicine evolves toward delivering the right drug to the right patient at the right time –– also known as personalized medicine.